Cargando…
Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study
Background. The cancer cell secretome has been recognized as a valuable reservoir for identifying novel serum/plasma biomarkers for different cancers, including colorectal cancer (CRC). This study aimed to verify four CRC cell-secreted proteins (tumor-associated calcium signal transducer 2/trophobla...
Autores principales: | Chiang, Sum-Fu, Kan, Chih-Yen, Hsiao, Yung-Chin, Tang, Reiping, Hsieh, Ling-Ling, Chiang, Jy-Ming, Tsai, Wen-Sy, Yeh, Chien-Yuh, Hsieh, Pao-Shiu, Liang, Ying, Chen, Jinn-Shiun, Yu, Jau-Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606116/ https://www.ncbi.nlm.nih.gov/pubmed/26494939 http://dx.doi.org/10.1155/2015/874054 |
Ejemplares similares
-
Rectal cancer level significantly affects rates and patterns of distant metastases among rectal cancer patients post curative-intent surgery without neoadjuvant therapy
por: Chiang, Jy Ming, et al.
Publicado: (2014) -
Concurrent colonic mucosa-associated lymphoid tissue lymphoma and adenoma diagnosed after a positive fecal occult blood test: a case report
por: Lin, Pei-Chiang, et al.
Publicado: (2016) -
Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk
por: Lai, I-Li, et al.
Publicado: (2019) -
A Prediction Model for Metachronous Peritoneal Carcinomatosis in Patients with Stage T4 Colon Cancer after Curative Resection
por: Tsai, Tzong-Yun, et al.
Publicado: (2021) -
Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients
por: Tsai, Wen-Sy, et al.
Publicado: (2016)